ATI RN
ATI RN Pharmacology 2023 V Questions
Extract:
Question 1 of 5
A nurse is reviewing a client's medical history before administering a new prescription for atropine. Which of the following client conditions is contraindicated?
Correct Answer: B
Rationale: The correct answer is B: Glaucoma. Atropine is contraindicated in clients with glaucoma due to its potential to increase intraocular pressure, worsening the condition. Bronchospasms (
A), diverticulitis (
C), and diarrhea (
D) are not contraindications for atropine administration. Bronchospasms can actually be treated with atropine, while diverticulitis and diarrhea are not directly affected by atropine administration. It is crucial to consider contraindications to ensure safe and effective medication administration.
Question 2 of 5
A nurse is planning to administer a prefilled syringe of enoxaparin to a client. Which of the following actions should the nurse take?
Correct Answer: C
Rationale:
Correct Answer: C - Administer the medication into the anterolateral or posterolateral abdominal area.
Rationale:
1. Enoxaparin is a low molecular weight heparin that is typically administered subcutaneously.
2. The anterolateral and posterolateral abdominal areas are recommended sites for subcutaneous injections due to the presence of a thick layer of adipose tissue and minimal risk of hitting blood vessels or nerves.
3. These areas have a larger surface area, which allows for better absorption and reduces the risk of tissue damage.
4. By selecting these specific areas, the nurse ensures proper administration and absorption of the medication.
Summary:
A: Massaging the injection site can cause bruising or tissue damage and is not recommended after administering enoxaparin.
B: Holding the skin taut is not necessary and may cause discomfort to the client during injection.
D: Expelling air bubbles is important to prevent air embolism but is not specific to the administration
Question 3 of 5
A nurse is caring for a client who has cirrhosis of the liver and is receiving spironolactone. Which of the following findings indicates that the client responding to the treatment?
Correct Answer: B
Rationale: The correct answer is B: Decreased ascites. Spironolactone is a diuretic commonly used to treat fluid retention in patients with cirrhosis. Ascites is the accumulation of fluid in the abdominal cavity, a common complication of liver cirrhosis. Improvement in ascites indicates that the spironolactone is effectively reducing fluid retention. Decreased jaundice (choice
A) is not directly related to spironolactone use. Increased energy (choice
C) and increased appetite (choice
D) are subjective and nonspecific findings that do not directly indicate response to spironolactone in treating ascites.
Question 4 of 5
A nurse is caring for a client who is to receive a corticosteroid injection. The client states, 'I am not taking that injection today.' Which of the following responses should the nurse make?
Correct Answer: D
Rationale: The correct response is D: "I will inform your provider about your decision." This response is appropriate because it respects the client's autonomy and decision-making capacity. By informing the provider, the nurse ensures that the healthcare team is aware of the client's refusal, enabling further discussion and exploration of alternatives.
Choice A may come off as confrontational and does not respect the client's decision.
Choice B disregards the client's autonomy and can damage the nurse-client relationship.
Choice C acknowledges the client's feelings but does not address the refusal directly.
Question 5 of 5
A nurse is planning care for a group of clients. Which of the following client's medications should be monitored by the nurse for hearing loss related to a medication interaction?
Correct Answer: A
Rationale: The correct answer is A: Furosemide and amikacin. Furosemide is a loop diuretic known to cause hearing loss, especially when used in combination with aminoglycosides like amikacin. Aminoglycosides can potentiate the ototoxic effects of loop diuretics, leading to hearing loss. Propranolol and raloxifene (
B), Digoxin and levothyroxine (
C), and Losartan and atorvastatin (
D) do not have known interactions leading to hearing loss. Monitoring Furosemide and amikacin combination is crucial to prevent adverse effects.